Welcome to LookChem.com Sign In|Join Free

CAS

  • or

307353-95-3

Post Buying Request

307353-95-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

307353-95-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 307353-95-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,7,3,5 and 3 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 307353-95:
(8*3)+(7*0)+(6*7)+(5*3)+(4*5)+(3*3)+(2*9)+(1*5)=133
133 % 10 = 3
So 307353-95-3 is a valid CAS Registry Number.
InChI:InChI=1/C11H7ClN2O2/c1-16-10-3-8-7(2-9(10)15)11(12)6(4-13)5-14-8/h2-3,5,15H,1H3

307353-95-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Chloro-6-hydroxy-7-methoxy-3-quinolinecarbonitrile

1.2 Other means of identification

Product number -
Other names 4-chloro-6-hydroxy-7-methoxyquinoline-3-carbonitrile

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:307353-95-3 SDS

307353-95-3Downstream Products

307353-95-3Relevant articles and documents

HETEROCYCLIC INHIBITORS OF TYROSINE KINASE

-

Paragraph 0479, (2020/11/03)

The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of HER2 or EGFR for the treatment or prevention of disease, including cancer.

Substituted quinolines as antitumor agents

-

, (2008/06/13)

The invention provides a compound of Formula (Ia), or a pharmaceutically acceptable salt. prodrug or solvate thereof. The invention also provides a process for the preparation of a compound of Formula (Ia), pharmaceutical compositions of a compound of Formula (Ia) and methods for the treatment or prevention of cancer comprising administering an effective amount of a compound of Formula (Ia).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 307353-95-3